From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

The Trump administration is impeding the National Institutes of Health-backed science that enabled treatment of ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Senators challenged Jay Bhattacharya, MD, PhD, President Donald Trump's pick to lead the National Institutes of Health (NIH), ...

A CDC report shows a dramatic drop in precancerous HPV lesions in young women. Here’s why the HPV vaccine is beneficial.

The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting U.S. automakers.

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

A University of Otago, Christchurch-led study is heralding the success of the HPV vaccination program, saying the cost and ...

New treatments for graft-vs.-host disease, updated dosage for HPV vaccines — and Fred Hutch announces awards for graduate students.